NCBiotech News

Grant funding from NCBiotech is helping NC State researchers take an early but important step in moving DNA storage from exciting idea to functional reality. 

A Durham startup, BIOMILQ, has a mission to replicate the nutritional profile of breastmilk with mammary cells outside the body.

Azzur Labs, an analytical laboratory serving the biopharmaceutical and medical device industries, has named Marie France Quillen as senior director of the expanding Raleigh operation.

Armed with federal grants and contracts totaling nearly $600 million, Duke has leased 273,000 square feet that will be retrofitted in the Parmer RTP research and development campus for vaccine development.

UK-based MedPharm Ltd., which completed a $4 million expansion in Research Triangle Park just six months ago, is at it again, this time in Durham.

Santo Costa, an attorney and long-time pharmaceutical executive, has been elected chairman of the North Carolina Biotechnology Center’s Board of Directors.

Durham's Bio Products Laboratory USA has launched two new plasma therapies covering six serious medical conditions, as it also works on developing a COVID-19 treatment.

Durham-based FoodLogiQ, is collaborating with three other food industry technology leaders to keep the food supply safer by identifying and tracking products, so food companies can respond faster, with better results, when safety issues arise.

Durham's Path BioAnalytics is teaming up with impact investors and a digital health company to find a cure for pancreatitis.

Advanced Animal Diagnostics is using a $50,000 grant from NCBiotech, through a program established by the Wells Fargo Foundation, to “repurpose” its blood test platform designed to detect disease in cattle, to add a screen for COVID-19 in humans.

“The future of biopharma is in females,” said Mycovia CEO Patrick Jordan earlier this week during a panel discussion at the BIO Digital life sciences conference.

NCBiotech provided a $250,000 loan to bootstrap CasTag BioSciences, a Duke spinout based on a technology that marks proteins in an entirely new way, using the genome-editing tool CRISPR. The resulting products are selling, and the potential is HiUGE.

Greensboro's Kepley BioSystems has developed a natural liquid called K9 Strategic Scent Stimulant to help dogs avoid distraction while you're socially distancing on COVID-era walks.

A LabCorp blood test that helps identify individuals who’ve been exposed to the COVID-19 coronavirus is now broadly available.

Audentes Therapeutics, a San Francisco company whose name changed to Astellas Gene Therapies on March 31, 2021, announced plans for a $109.4 million, 209-employee gene therapy production facility in Sanford, a short distance from a $600 million Pfizer gene therapy campus under construction.